Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genakumab vs Diprospan in Acute Gouty Arthritis
NCT05983445Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jan 2023
- Primary completion
- Apr 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of genakumab in gouty arthritis, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jan 2023; status: completed.
02
Drugs
genakumab
03
Conditions
gouty arthritis
Beyond the preview
Go deeper on NCT05983445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983445.